Milestone Advisory Partners’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
SCA
Milestone Advisory Partners's LMAT Position: Q1 2022 in Review
Milestone Advisory Partners sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 4,648 shares — an estimated $233K sold.
Milestone Advisory Partners first reported a position in LMAT in Q1 2021 and held it in 4 quarters. The position peaked at $284K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.
- Milestone Advisory Partners reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
- Milestone Advisory Partners sold 4,648 LeMaitre Vascular shares in Q1 2022, an estimated $233K.
- Milestone Advisory Partners first reported a position in LeMaitre Vascular in Q1 2021 and held it in 4 quarters.
- Milestone Advisory Partners's LeMaitre Vascular position peaked at $284K in Q2 2021.
- 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.
Based on Milestone Advisory Partners's 13F filing for Q1 2022, filed 10 May 2022.